Functional change of the auditory cortex related to brain serotonergic neurotransmission in type 1 diabetic adolescents with and without depression

World Journal of Biological Psychiatry

Volumn 10, Issue 4 PART 3, 2009, Pages 877-883

  Manjarrez Gutierrez, Gabriel ^a   Marquez, Rocio Herrera ^b   Mejenes Alvarez, Susana A ^b   Godinez Lopez, Teresa ^a   Hernandez R, Jorge ^c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Auditory evoked potentials (N1 P2 component); Brain serotonin; Depression; Type 1 diabetes

Indexed keywords

ALBUMIN; FATTY ACID; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; TRYPTOPHAN; ALBUMINOID; SEROTONIN;

ADOLESCENT; ARTICLE; AUDITORY CORTEX; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLIC REGULATION; PATIENT COMPLIANCE; SEROTONINERGIC TRANSMISSION; BLOOD; BRAIN; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; MAJOR DEPRESSION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ADOLESCENT; ALBUMINS; AUDITORY CORTEX; BLOOD GLUCOSE; BRAIN; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS, TYPE 1; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EVOKED POTENTIALS, AUDITORY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; SEROTONIN; SEVERITY OF ILLNESS INDEX; SYNAPTIC TRANSMISSION; TRYPTOPHAN;

EID: 77949514002     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970902717032     Document Type: Article

References (50)

1. American Psychiatric Association. Task Force on DSM-IV. 1994. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association.
2. Bentley R. 1963. Glucose oxidase in the enzymes. In: Boyer PD, editor. The enzymes. New York: Academic Press. pp 567-586.
3. Blanz BJ, Rensch-Riemann BS, Fritz-Sigmund DI, Schmidt MH. 1993. IDDM is a risk factor for adolescent psychiatric disorders. Diabetes Care 16:1579-1587
4. Broderick PA, Jacoby JH. 1988. Serotonergic function in diabetic rats: psychotherapeutic implications. Biol Psychiatry 24: 234-239.
5. Brownlee M. 2005. The pathobiology of diabetic complications. Diabetes 54:1615-1625.
6. Ciechanowski PS, Katon WJ, Russo JE. 2000. Depression and diabetes: impact of depressive symptoms on adherence, function and costs. Arch Intern Med 160:3278-3285.
7. Cole RA, Soeldner JS., Dunn PJ. 1978. A rapid method for the determination of glycosylated hemoglobin using high-pressure liquid chromatography. Metabolism 27:289-301.
8. Comi G. 1997. Evoked potentials in diabetes mellitus. Clin Neurosci 4:374-379.
9. Doumas BT, Watson WA, Biggs HG. 1971. Albumin standards: the measurement of serum albumin with bromocresol green. Clin Chim Acta 31:87-96.
10. Ehlers CL, Wall TL, Chaplin RL. 1991. Long latency event-related potentials in rats: effects of dopaminergic and serotonergic depletions. Pharmacol Biochem Behav 38:789-793.
11. Gavard JA, Lustman PJ, Clouse RA. 1993. Prevalence of depression in adults with diabetes: an epidemiologic evaluation. Diabetes Care 16:1167-1178.
12. Hegerl U, Juckel G. 1993. Intensity dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 33:173-187.
13. Hermanns N, Kulzer B, Krichbaun T, Kubiak T, Haak T 2005. Affective and anxiety disorders in a german sample of diabetic patient: prevalence, comorbidity and risk factors. Diabetic Medicine 22:293-300.
14. Herrera R, Manjarrez G, Nishimura E, Hernandez J. 2003. Serotonin-related tryptophan in children with insulin-dependent diabetes. Pediatr Neurol 28:20-23.
15. Herrera R, Manjarrez G, Hernandez J. 2005. Inhibition and kinetic changes of brain tryptophan-5-hydroxylase during insulin-dependent diabetes mellitus in the rat. Nutr Neurosci 8:57-62.
16. Jacobs BL, Azmitia EC. 1992. Structure and function of the brain serotonin system. Physiol Rev 72:165-229.
17. Jouvet M. 1999. Sleep and serotonin: an unfinished story. Neuropsychopharmacology 21:24-27S.
18. Juckel G, Molnar M, Hegerl U, Csepe V, Karmos G. 1997. Auditory-evoked potentials as indicator of brain serotonergic activity\first evidence in behaving cats. Biol Psychiatry 41:1181-1195.
19. Katon W, Von Korff M, Ciechanowski P, Russo J, Lin E, Simon G, et al. 2004. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 27:914-920.
20. Kovacs M, Obrosky DS, Goldston D, Drash A. 1997a. Major depressive disorder in youths with IDDM: a controlled prospective study of course and outcome. Diabetes Care 20:45-51.
21. Kovacs M, Goldston D, Obrosky DS, Bonar LK. 1997b. Psychiatric disorders in youths with IDDM: rate and risk factors. Diabetes Care 20:36-44.
22. Lawrence J, Standiford D, Loots B, Klingensmiths G. 2006. Prevalence and correlates of depressed mood among youth with diabetes: The SEARCH for diabetes in youth study. Pediatrics 117:1348-1358.
23. Liang Y, Luo S, Cincotta AH. 1999. Long-term infusion of norepinephrine plus serotonin into the ventromedial hypothalamus impairs pancreatic islet function. Metabolism 48: 1287-1289.
24. Mann JJ. 1999. Role of the serotonergic system in the pathogenesis of major depression and suicidal bahavior. Neuropsycho-pharmacology 21:99S-105S.
25. McCall RB, Clement ME. 1994. Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system. Pharmacol Rev 46:231-243.
26. Manjarrez G, Herrera R, Molina A, Bueno S, Gonzalez M, Hernandez J. 1999. Alteraciones en la ś?ntesis de serotonina cerebral inducidas por diabetes mellitus insulino dependiente. Rev Invest Cĺ?n 51:293-302.
27. Manjarrez G, Herrera R, Bueno S, Gonzalez M, Hernandez J. 2000. Cambios en la bioś?ntesis de serotonina cerebral en ratas con diabetes mellitus inducida por estreptozotocina: efecto del tratamiento con insulina. Rev Invest Clin 52:509-516.
28. Manjarrez GG, Hernandez ZE, Robles OA, Gonzalez RM, Hernandez RJ. 2001. Development impairment of auditory evoked N1/P2 component in rats undernourished in utero: its relation to brain serotonin activity. Dev Brain Res 127: 149-155.
29. Manjarrez G, Cisneros I, Herrera R, Vazquez F, Robles A, Hernandez J. 2005a. Prenatal impairment of brain serotonergic transmission in infants. J Pediatr 147:592-596.
30. Manjarrez GG, Hernandez SE, Robles OA, Hernandez-RJ. 2005b. N1/P2 component of auditory evoked potential reflect changes of the brain serotonin biosynthesis in rats. Nutr Neurosci 8:213-218.
31. Manjarrez G, Herrera R, Leon M, Hernandez J. 2006. A low brain serotonergic neurotransmission in children with type 1 diabetes detected through the intensity dependence of auditory evoked potentials. Diabetes Care 29:73-77.
32. Manjarrez G, Vazquez F, Delgado M, Herrera R, Hernandez J. 2007. A functional disturbance in the auditory cortex related to a low serotonergic neurotransmission in women with type 2 diabetes. Neuroendocrinology 86:289-294.
33. Meltzer HY. 1990. Role of serotonin in depression. Ann NY Acad Sci 600:486-499
34. Mendez FJ, Belendez M. 1997. Effects of behavioural intervention on treatment adherence and stress management in adolescents with IDDM. Diabetes Care 20:1370-1375.
35. Messing RB, Lytle LD. 1977. Serotonin containig neurons: their possible role in pain and analgesia. Pain 4:1-21.
36. Mossner R, Mikova O, Koutsilieri E, Saoud M, Ehlis AC, Müller N, et al. 2007. Consensus paper of the WFSBP task force on biological markers: biological marks in depression. World J Biol Psychiatry 8:141-174.
37. Moller HJ. 2008. Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment. World J Biol Psychiatry 9:102-114.
38. Peat MA, Gibb JW 1983. High-performance liquid chromatography determination of indoleamines, dopamine, and norepinephrine in rat brain with fluorometric detection. Anal Biochem 128:275-280.
39. Prestels S, Aldenhoff J, Reiff J. 2003. The HPA-axis as a possible link between depression, diabetes mellitus and cognitive dysfunction. Fortschr Neurol Psychiatr 71:24-36.
40. Ramage AG. 2001. Central cardiovascular regulation and 5-hydroxytryptamine receptors. Brain Res Bull 56:425-439.
41. Sadler E, Weiner M, Buterbaugh GG. 1983. Effect of streptozotocin-induced diabetes on tryptophan oxygenase activity and brain trytophan levels in rats. Res Commun Chem Pathol Pharmacol 42:37-50.
42. Schildkraut JJ, Kety SS. 1967. Biogenic amines and emotion. Science 156:21-30.
43. Semple MN, Scott BH. 2003. Cortical mechanism in hearing. Curr Opin Neurobiol 13:167-173.
44. Shor-Posner G, Grinker AJ, Marinescu C, Brown O, Leibowitz FS. 1986. Hypothalamic serotonin in the control of meal patterns and macronutrient selection. Brain Res Bull 17: 663-671. (Pubitemid 17200136)
45. Surgenor LJ, Horn J, Hudson SM. 2002. Links between psychological sense of control and disturbed eating behavior in women with diabetes mellitus. Implications for predictors of metabolic control. J Psychosom Res 52:121-128
46. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. 2000. Diabetes Care 23(Suppl 1):S4-19.
47. Uberall MA, Renner C, Edl S, Parzinger E, Wenzel D. 1996. VEP and ERP abnormalities in children and adolescents with pre-pubertal onset on insulin-dependent diabetes mellitus. Neuropediatrics 27:88-93.
48. Von Knorring L, Monakhov K, Perris C. 1978. Augmenting/reducing: an adaptive switch mechanism to cope with incoming signals in healthy subjects and psychiatric patients. Neuropsy-chobiology 4:150-179.
49. Wilkinson G, Borsey DQ, Leslie P, Newton RW, Lind C, Ballinger CB. 1988. Psychiatric morbidity and social problems in patients with insulin-dependent diabetes mellitus. Br J Psychiatry 153:38-43
50. Zhou Fu-Ming, Hablitz JJ. 1999. Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J Neurophysiol 82:2989-2999.